Uveitis, Posterior: Clinical Trials

10 trials for Uveitis, Posterior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed, 1 terminated, 1 withdrawn. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Unknown 5, Completed 3, Terminated 1, Withdrawn 1

Follow Uveitis, Posterior: new trials by email Literature Review of Uveitis, Posterior trials Research Report on Uveitis, Posterior

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Fluocinolone Acetonide Intravitreal Implant 0.18 mg - Uveitis, Posterior
Phase 4UnknownAlimera Sciences1252022-06-062024-08-06
Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
Ixekizumab Prefilled Syringe - Uveitis, Posterior, Uveitis, Anterior
Phase 4UnknownMassachusetts Eye Research and Surgery Institution202022-06-012023-10-16
Ozurdex Monotherapy Trial
Ozurdex 0.7mg Ophthalmic Implant, Prednisone - Uveitis, Posterior, Uveitis, Intermediate
Phase 4WithdrawnOttawa Hospital Research Institute2021-11-302025-03-12
Six-months Versus Nine-months ATT for Ocular TB
Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis
Phase 4CompletedL.V. Prasad Eye Institute582020-01-012024-09-26
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
Acthar Gel - Uveitis, Posterior, Uveitis, Intermediate
Phase 4TerminatedMallinckrodt52018-10-052021-08-03
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
H.P. ACTHAR GEL - Uveitis, Posterior, Vasculitis Retinal
Phase 4UnknownOcular Immunology and Uveitis Foundation402017-03-222019-09-12
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
H.P. ACTHAR SUBCUTANEOUS GEL INJECTION - Uveitis, Anterior Uveitis
Phase 4CompletedTampa Bay Uveitis Center, LLC62016-06-302018-07-02
Study of the Effectiveness of Ozurdex for the Control of Uveitis
Dexamethasone pellet - Uveitis, Intermediate, Uveitis, Posterior
Phase 4CompletedJohns Hopkins University202014-01-012019-07-05
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
methylorednisolone, dextrose water 5% - Behcet's Disease
Phase 4UnknownTehran University of Medical Sciences342010-02-012011-03-02
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
flucinolone acetonide - Ocular Behcet's Disease,, Non-Infectious Uveitis
Phase 4UnknownAsan Medical Center152008-07-012008-07-29

Narrower conditions

Uveitis, Intermediate (5)  ·  Uveitis (4)  ·  Panuveitis (3)  ·  Retinal Vasculitis (3)  ·  Behcet Syndrome (2)  ·  Uveitis, Anterior (2)  ·  Choroiditis (1)  ·  Eye Abnormalities (1)  ·  Eye Diseases (1)  ·  Inflammation (1)  ·  Scleritis (1)  ·  Tuberculosis (1)  ·  Vision Disorders (1)

Broader conditions

Uveal Diseases (10)  ·  Eye Diseases (9)  ·  Panuveitis (7)  ·  Uveitis (6)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Vasculitis (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Retinal Diseases (3)  ·  Genetic Diseases, Inborn (2)  ·  Hereditary Autoinflammatory Diseases (2)  ·  Mouth Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin Diseases, Vascular (2)

Interventions

Adrenocorticotropic Hormone (2)  ·  Fluocinolone Acetonide (2)  ·  Calcium Dobesilate (1)  ·  Prednisone (1)  ·  Vision, Ocular (1)

Sponsors

Alimera Sciences (1)  ·  Asan Medical Center (1)  ·  Johns Hopkins University (1)  ·  L.V. Prasad Eye Institute (1)  ·  Mallinckrodt (1)  ·  Massachusetts Eye Research and Surgery Institution (1)  ·  Ocular Immunology and Uveitis Foundation (1)  ·  Ottawa Hospital Research Institute (1)  ·  Tampa Bay Uveitis Center, LLC (1)  ·  Tehran University of Medical Sciences (1)

Countries

United States (6)  ·  Burma (1)  ·  Canada (1)  ·  India (1)  ·  Iran (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Antonio Cutino (1)  ·  C. Stephen Foster, MD, FACS, FACR (1)  ·  Farhad Shahram, Professor (1)  ·  Grace L Clarke (1)  ·  Jennifer E Thorne, MD, PhD (1)  ·  Young Hee Yoon, MD (1)